[1]
Fangyin Chou and Wei Tang, “Modulation of ACE2 Glycosylation as a Therapeutic Target for SARS-CoV-2 Infection in Chinese Populations”, sjim, vol. 2, no. 1, pp. 37-48, Nov. 2023.